Magnitude Biosciences

Magnitude Biosciences Limited is a contract research organisation providing preclinical drug discovery and compound screening services using Caenorhabditis elegans as a whole-organism model.

Its proprietary biophotonics platform enables automated, high-throughput, non-invasive monitoring of health and lifespan metrics across large worm populations, supporting compound library screening, pathway analysis, microbiome assessment, and toxicology studies.

The platform accelerates early compound triage for pharmaceutical, biotechnology, and nutrition clients, reducing reliance on mammalian models.